Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands.

Meijer, Rick I; Hoekstra, Trynke; van den Oever, Niels C Gritters; Simsek, Suat; van den Bergh, Joop P; Douma, Renée A; Reidinga, Auke C; Moeniralam, Hazra S; Dormans, Tom; Smits, Mark M

Meijer, Rick I; Hoekstra, Trynke; van den Oever, Niels C Gritters; Simsek, Suat; van den Bergh, Joop P; Douma, Renée A; Reidinga, Auke C; Moeniralam, Hazra S; Dormans, Tom; Smits, Mark M.

Afiliação

Meijer RI; Department of Internal Medicine, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
Hoekstra T; Department of Health Sciences and Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
van den Oever NCG; Department of Intensive Care Medicine, Treant Zorggroep Emmen, Emmen, The Netherlands.
Simsek S; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands.
van den Bergh JP; Department of Internal Medicine, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands.
Douma RA; Department of Internal Medicine, Viecuri, Venlo, The Netherlands.
Reidinga AC; Department of Internal Medicine, Flevohospital, Almere, The Netherlands.
Moeniralam HS; Department of Intensive Care Medicine, Martini Hospital, Groningen, The Netherlands.
Dormans T; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.

J Diabetes Metab Disord ; 20(2): 1155-1160, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34222054

Palavras-chave

COVID-19; DPP-4 inhibitors; Mortality; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google